BioLab Holdings, Inc. recently announced the launch of a multicenter hybrid platform trial evaluating the clinical real-world ...

June 30, 2025—The Society for Cardiovascular Angiography & Interventions (SCAI) announced the publication of new, evidence-based clinical practice guidelines to support the treatment of chronic venous ...

July 1, 2025—Teleflex Incorporated announced that it has completed the acquisition of substantially all of the Vascular Intervention business of Biotronik. On February 27, 2025, Teleflex announced it ...

June 30, 2025—Verge Medical announced the acquisition of the RoVo system and its temporary occlusion embolectomy (TOE) technology from 2MG Medical. The FDA-cleared RoVo system addresses the risk of ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-249. doi: ...

June 16, 2025—InspireMD, Inc. recently announced it has received CE Mark approval under the European Medical Device Regulation (EU MDR) for the CGuard Prime embolic protection system (EPS), a MicroNet ...

June 11, 2025—HistoSonics, Inc. recently announced the completion of patient enrollment in the #HOPE4KIDNEY pivotal trial of its Edison histotripsy system. The Edison platform uses a nonthermal, ...

June 18, 2025—Anaconda Biomed, SL, announced that it has received CE Mark certification for its ANA5 advanced neurovascular access funnel catheter. The CE Mark enables eventual commercial availability ...

June 23, 2025—Endovascular Engineering, Inc. (E2) announced the completion of patient enrollment in the pivotal cohort of the ENGULF investigational device exemption (IDE) study of its Helo ...

June 11, 2025—Medtronic announced the treatment of the first patient in the United States in the GSR-DEFINE clinical trial. The clinical study is documenting the safety and effectiveness of the ...

How do you currently define medium vessel occlusion (MeVO) in your practice? Dr. Goyal: MeVO is defined based on our publication in Journal of Neurointerventional Surgery. 1 The three criteria are: (1 ...